# Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone

> **NCT00268567** · PHASE2,PHASE3 · COMPLETED · sponsor: **Peking University**

## Conditions studied

- Nephritis, Lupus

## Interventions

- **DRUG:** leflunomide combined with prednisone

## Key facts

- **NCT ID:** NCT00268567
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00268567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00268567, "Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00268567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*